References
Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA et al. Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018;72:2231-2264.
Saenger AK, Beyrau R, Braun S, Cooray R, Dolci A, Freidank H et al. Multicenter analytical
evaluation of a high-sensitivity troponin T assay. Clin Chim Acta. 2011;412:748-754.
  1. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system For cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9-13.
  2. Cohen J. ”A power primer”. Psychological Bulletin.1992;112:155-159.
  3. G Landoni , F Pappalardo, M G Calabrò, F Boroli, O Sottocorna, G Aletti et al. Myocardial necrosis biomarkers after different cardiac surgical operations. Minerva Anestesiol. 2007;73:49-56.
  4. Mokhtar AT, Begum J, Buth KJ, Legare JF. Cardiac troponin T is an important predictor of mortality after cardiac surgery. J Crit Care. 2017;38:41-46.
  5. Nam K, Shin KW, Kim TK, Kim KH, Kim KB, Jeon Y et al. Prognostic value of high-sensitivity troponin I after cardiac surgery according to preoperative renal function. Medicine (Baltimore) 2020;99:e20040.
  6. Wang TK, Stewart RA, Ramanathan T, Kang N, Gamble G, White HD. Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the universal definition of MI. Eur Heart J Acute Cardiovasc Care. 2013;2:323-333.
  7. Yang G, Yao Y, Du Y, Huang J. Cardiac troponin had limited diagnostic value for acute myocardial infarction in renal insufficiency: a meta-analysis. Biomark Med. 2020;14:481-493.
  8. Hsu CK, Wu IW, Chen YT, Peng CH, Tseng YJ, Chen YC et al. Value of the high-sensitivity troponin T assay for diagnosis of acute myocardial infarction in patients with and without renal insufficiency.2020;42:1142-1151.
  9. Martínez-Comendador J, Castaño M, Mosquera I, Plana JG, Gualis J, Martín CE et al. Cryoablation of atrial fibrillation in cardiac surgery: outcomes and myocardial injury biomarkers. J Cardiothorac Vasc Anesth. 2011;25:1030-1035.
  10. Mohammed AA, Agnihotri AK, van Kimmenade RR, Martinez-Rumayor A, Green SM, Quiroz R et al. Prospective, comprehensive assessment of cardiac troponin T testing after coronary artery bypass graft surgery. Circulation. 2009;120:843-850.
  11. Januzzi JL Jr. Troponin testing after cardiac surgery. HSR Proc Intensive Care Cardiovasc Anesth. 2009;1:22-32
  12. Stone GW, Kappetein AP, Sabik JF, Pocock SJ, Morice MC, Puskas J et al. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease. N Engl J Med. 2019;381:1820-1830.
  13. Ramsay J, Shernan S, Fitch J, Finnegan P, Todaro T, Filloon T et al. Increased creatine kinase
MB level predicts postoperative mortality after cardiac surgery independent of new Q waves. J Thorac Cardiovasc Surg. 2005;129:300-306.
Gavard JA, Chaitman BR, Sakai S, Stocke K, Danchin N, Erhardt L et al. GUARd During Ischemia Against Necrosis (GUARDIAN) Investigators. Prognostic significance of elevated creatine Kinase MB after coronary bypass surgery and after an acute coronary syndrome: results from the GUARDIAN trial. J Thorac Cardiovasc Surg. 2003;126:807-813.